Pregabalin
Carpal Tunnel Syndrome (CTS)
University of FaisalabadSmall moleculeN/AActive
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
2 Active assets in the Carpal Tunnel Syndrome (CTS) cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
EVUZAMITIDE University of Tennessee Graduate School of Medicine | Phase 2 | CCC |
LIDOCAINE Haydarpasa Numune Training and Research Hospital | D |
Same molecule, other indications
Pregabalin is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →